Home › Focal Segmental Glomerulosclerosis › New York › New York City
Focal Segmental Glomerulosclerosis clinical trials in New York City, NY
7 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RecruitingPhase 2
- Columbia University Irving Medical Center- Site Number : 8400001, New York
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
Recruiting
- Weill Cornell Medicine / NewYork-Presbyterian, New York
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Recruiting
- Weill Cornell Medical Center / NewYork-Presbyterian, New York
NEPTUNE Match Study
Recruiting
- Columbia University Medical Center, New York
Nephrotic Syndrome Study Network
RecruitingObservational study
- New York University Medical Center, New York
- Bellevue Hospital, New York
- New York University Veterans Administration, New York
- and 1 more
AMPK-activation by Metformin in FSGS: AMP-FSGS
RecruitingPhase 1/2
- Mount Sinai Hospital, New York
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
RecruitingPhase 3
- Icahn School of Medicine at Mount Sinai, New York
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- Queens, NY6 studies
- Ann Arbor, MI6 studies
- Miami, FL6 studies
- Los Angeles, CA6 studies
- Atlanta, GA5 studies
- Houston, TX5 studies
- Chicago, IL4 studies
- Kansas City, MO4 studies
- Cleveland, OH4 studies
- Dallas, TX4 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.